Skip to main content
HNGE
NYSE Technology

Executive Chairman Mecklenburg Files to Sell $35.3M in Hinge Health Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$88.59
Mkt Cap
$7.149B
52W Low
$30.08
52W High
$95.57
52W Position info
195% above low
Off High info
7.3% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

HNGE has more than doubled off its 52-week low of $30.08.

Summary

Executive Chairman Gabriel Mecklenburg filed to sell 400,000 shares (~$35.3M) under a pre-existing 10b5-1 plan, adding to $7.1M in sales over the past three months.


Key Events · Ownership and Investor Activity · HNGE

  • Executive Chairman Files to Sell $35.3M

    Gabriel Mecklenburg, Executive Chairman and Co-Founder, filed a Form 144 to sell 400,000 shares with an approximate market value of $35.3 million.

  • 10b5-1 Plan Pre-Scheduled

    The sale is executed under a 10b5-1 trading plan adopted on June 12, 2026, indicating the sale was pre-planned and not a reaction to current market conditions.

  • Prior Sales Under Same Plan

    Over the past three months, Mecklenburg sold 83,334 shares for gross proceeds of $7.09 million under the same 10b5-1 plan.

  • Broader Insider Distribution

    This filing adds to a pattern of heavy insider selling, with $238.4 million in open-market sales by insiders over the past 90 days, primarily from institutional investor Insight Venture Partners.


Analysis · HNGE · Technology

Gabriel Mecklenburg, Executive Chairman and Co-Founder, has filed a Form 144 to sell 400,000 shares worth approximately $35.3 million. The sale is executed under a 10b5-1 plan adopted on June 12, 2026, which means it was pre-scheduled and not a reaction to current market conditions. This follows $7.1 million in sales over the past three months under the same plan. While the sale is significant in dollar terms, it represents a routine, pre-planned liquidation by a founder-executive rather than a sudden loss of confidence. The broader context shows heavy institutional selling by Insight Venture Partners over the past 90 days, but this filing is from a different insider and adds a new layer of insider distribution.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.2% of the 1943 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HNGE was trading at $88.59 on NYSE in the Technology sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $30.08 to $95.57. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HNGE - Latest Insights

HNGE
Aug 04, 2026, 6:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $78.74
Real-time Price: $88.59 info
Change: +$9.85 (+13%) info
Market Cap: $7.149B info
HNGE
Aug 04, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $76.49
Real-time Price: $88.59 info
Change: +$12.10 (+16%) info
Market Cap: $7.149B info
HNGE
Aug 04, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $77.01
Real-time Price: $88.59 info
Change: +$11.58 (+15%) info
Market Cap: $7.149B info
HNGE
Jul 07, 2026, 5:48 PM EDT
Filing Type: 144/A
Importance Score:
8
Price at Filing: $88.80
Real-time Price: $88.59 info
Change: -$0.210 (-0.24%) info
Market Cap: $7.149B info
HNGE
Jul 07, 2026, 4:46 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $89.30
Real-time Price: $88.59 info
Change: -$0.710 (-0.80%) info
Market Cap: $7.149B info